Creative Planning - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.8%.

Quarter-by-quarter ownership
Creative Planning ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$5,000
-50.0%
26,206
+22.6%
0.00%
Q3 2018$10,000
+25.0%
21,376
+40.3%
0.00%
Q2 2018$8,000
-96.9%
15,236
-86.0%
0.00%
-100.0%
Q1 2018$254,0000.0%109,216
+22.3%
0.00%0.0%
Q4 2017$254,000
+9.5%
89,286
+9.8%
0.00%0.0%
Q3 2017$232,000
+17.2%
81,286
+1.4%
0.00%0.0%
Q2 2017$198,000
-23.3%
80,136
+12.2%
0.00%0.0%
Q1 2017$258,000
+8.4%
71,420
+6.1%
0.00%0.0%
Q4 2016$238,000
+6.2%
67,336
+21.7%
0.00%0.0%
Q3 2016$224,000
+873.9%
55,346
+971.4%
0.00%
Q2 2016$23,000
+27.8%
5,166
+8.4%
0.00%
Q1 2016$18,000
-92.0%
4,766
-66.7%
0.00%
-100.0%
Q4 2015$225,000
+281.4%
14,323
+154.7%
0.00%
+100.0%
Q3 2015$59,000
-39.8%
5,623
+60.4%
0.00%0.0%
Q1 2015$98,000
+75.0%
3,506
+14.1%
0.00%0.0%
Q4 2014$56,000
+100.0%
3,074
+44.5%
0.00%
Q3 2014$28,000
-91.6%
2,128
-93.4%
0.00%
-100.0%
Q2 2014$332,000
+33100.0%
32,274
+43513.5%
0.00%
Q1 2014$1,000
-50.0%
740.0%0.00%
Q4 2013$2,0000.0%74
+37.0%
0.00%
Q3 2013$2,000540.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2018
NameSharesValueWeighting ↓
Ridgeback Capital Investments L.P. 1,025,000$24,815,00031.36%
TSP Capital Management Group, LLC 836,342$20,248,0008.80%
Iguana Healthcare Management, LLC 200,000$4,842,0002.76%
First Light Asset Management, LLC 116,096$2,811,0002.38%
SECTORAL ASSET MANAGEMENT INC 2,227,688$53,932,0002.33%
BENNETT LAWRENCE MANAGEMENT L L C/NY 550,735$13,334,0002.05%
Eventide Asset Management 257,000$6,222,0001.92%
Redmile Group, LLC 397,951$9,634,0001.19%
ARDSLEY ADVISORY PARTNERS LP 357,000$8,643,0001.15%
Rhenman & Partners Asset Management AB 90,000$2,179,0000.85%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders